Accord Healthcare Ltd will supply hydroxychloroquine to the COPCOV study. The trial will see if the anti-malarial can prevent doctors catching COVID-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Fox_Claire . Well, of course they are. Trump's solution of choice, but no evidence it works.
What were they waiting for?
Sanofi won't mind that 1 bit. They will get the credit and a huge boost.
Fox_Claire Make sure it’s not made in China.... CCP
hI? 'If ongoing clinical studies demonstrate its efficacy and safety, Sanofi will continue to donate the medicine.' by sanofi
Fox_Claire I hope they're giving some of it to lupus patients who can't get it now.
hydroxylchloroquinne has some adverse side effects